Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone modifying activity

HUWE1 KDM6B

4.47e-0322992GO:0140993
GeneOntologyMolecularFunctionstructural molecule activity

ANK3 KRT13 NUP62CL

6.08e-0389193GO:0005198
DomainUBA

TNRC6C HUWE1

8.92e-053092SM00165
DomainUBA

TNRC6C HUWE1

1.29e-043692PF00627
DomainUBA

TNRC6C HUWE1

1.93e-044492IPR015940
DomainUBA

TNRC6C HUWE1

2.21e-044792PS50030
DomainUBA-like

TNRC6C HUWE1

4.10e-046492IPR009060
PathwayREACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE

TNRC6C PHC3 KDM6B

3.69e-0512583M27186
PathwayREACTOME_CELLULAR_SENESCENCE

TNRC6C PHC3 KDM6B

1.43e-0419783M27188
PathwayWP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS

ANK3 CADM1

2.40e-044282MM15822
PathwayWP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS

ANK3 CADM1

2.40e-044282M39703
PathwayREACTOME_ADHERENS_JUNCTIONS_INTERACTIONS

CADM1 TNRC6C

4.58e-045882M11980
PathwayREACTOME_CELL_CELL_JUNCTION_ORGANIZATION

CADM1 TNRC6C

1.10e-039082M820
PathwayREACTOME_CELL_JUNCTION_ORGANIZATION

CADM1 TNRC6C

1.85e-0311782M19248
PathwayREACTOME_PTEN_REGULATION

TNRC6C PHC3

2.60e-0313982M27646
PathwayREACTOME_CELL_CELL_COMMUNICATION

CADM1 TNRC6C

3.22e-0315582M522
PathwayREACTOME_DEVELOPMENTAL_BIOLOGY

ANK3 KRT13 TNRC6C KDM6B

5.31e-03143284M509
Pubmed

Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne.

TNRC6C HUWE1

7.25e-05509231699778
Pubmed

The DNA sequence of the human X chromosome.

HUWE1 AFF2 NUP62CL

1.27e-044079315772651
Pubmed

Interaction between the scaffold proteins CBP by IQGAP1 provides an interface between gene expression and cytoskeletal activity.

HUWE1 KDM6B

1.38e-04699232238831
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ANK3 PHC3 AFF2

1.49e-044309335044719
Pubmed

Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.

TNRC6C HUWE1

1.68e-04769227542412
Pubmed

Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.

ANK3 CADM1

1.96e-04829231073041
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ANK3 CADM1 HUWE1 KDM6B

2.01e-0412859435914814
Pubmed

Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.

KRT13 HUWE1

2.05e-04849229563501
InteractionAGR2 interactions

ANK3 HUWE1 PHC3 AFF2 NUP62CL

2.28e-0593495int:AGR2
CoexpressionONDER_CDH1_TARGETS_2_DN

ANK3 KRT13 CADM1 NUP62CL

1.23e-0547394M4306
CoexpressionGSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP

TNRC6C AFF2 KDM6B

3.50e-0519993M7414
CoexpressionDURCHDEWALD_SKIN_CARCINOGENESIS_DN

ANK3 KRT13 CADM1

8.21e-0526593M1684
CoexpressionDURCHDEWALD_SKIN_CARCINOGENESIS_DN

ANK3 KRT13 CADM1

8.86e-0527293MM1027
CoexpressionULE_SPLICING_VIA_NOVA2

ANK3 CADM1

9.40e-054392M1551
CoexpressionULE_SPLICING_VIA_NOVA2

ANK3 CADM1

9.40e-054392MM666
CoexpressionBURTON_ADIPOGENESIS_2

ANK3 KRT13

2.57e-047192M1582
CoexpressionBURTON_ADIPOGENESIS_2

ANK3 KRT13

2.65e-047292MM673
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

ANK3 CADM1 TNRC6C AFF2

3.35e-04110694M39071
CoexpressionNGUYEN_NOTCH1_TARGETS_DN

CADM1 HUWE1

3.52e-048392M14650
CoexpressionRATTENBACHER_BOUND_BY_CELF1

HUWE1 AFF2 NUP62CL

3.76e-0444493M2505
CoexpressionZHONG_PFC_C3_MICROGLIA

ANK3 CADM1 TNRC6C

4.96e-0448893M39104
CoexpressionTABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING

CADM1 KDM6B

8.20e-0412792MM3856
CoexpressionSTEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP

ANK3 CADM1

8.33e-0412892M4925
CoexpressionFOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP

ANK3 PHC3 NUP62CL

8.49e-0458793M40869
CoexpressionSTEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP

ANK3 CADM1

9.12e-0413492MM748
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_DN

ANK3 HUWE1 AFF2

9.49e-0461093M3854
CoexpressionMARTINEZ_TP53_TARGETS_DN

ANK3 HUWE1 AFF2

9.72e-0461593M8673
CoexpressionSARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN

ANK3 KRT13

1.07e-0314592M11513
CoexpressionZHONG_PFC_C4_PTGDS_POS_OPC

ANK3 CADM1

1.10e-0314792M39099
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_DN

ANK3 HUWE1 AFF2

1.14e-0365093MM1042
CoexpressionMARTINEZ_TP53_TARGETS_DN

ANK3 HUWE1 AFF2

1.19e-0365993MM1040
CoexpressionGSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN

TNRC6C PHC3

1.39e-0316692M6826
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HNBGABA

ANK3 CADM1 TNRC6C

1.43e-0370393M39070
CoexpressionGSE15659_TREG_VS_TCONV_DN

ANK3 HUWE1

1.78e-0318892M3535
CoexpressionGSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP

ANK3 NUP62CL

1.84e-0319192M6076
CoexpressionGSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN

PHC3 NUP62CL

1.86e-0319292M6064
CoexpressionGAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP

ANK3 HUWE1

1.92e-0319592M1110
CoexpressionEGFR_UP.V1_DN

ANK3 CADM1

1.93e-0319692M2633
CoexpressionGSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP

CADM1 AFF2

1.97e-0319892M5215
CoexpressionGSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN

TNRC6C PHC3

1.99e-0319992M9236
CoexpressionGSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP

CADM1 HUWE1

1.99e-0319992M5365
CoexpressionGSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN

ANK3 AFF2

1.99e-0319992M4635
CoexpressionGSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP

CADM1 AFF2

1.99e-0319992M5197
CoexpressionGSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP

ANK3 CADM1

2.01e-0320092M9060
CoexpressionGSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN

CADM1 PHC3

2.01e-0320092M7469
CoexpressionGSE31082_DN_VS_DP_THYMOCYTE_DN

TNRC6C KDM6B

2.01e-0320092M5055
CoexpressionGSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP

ANK3 CADM1

2.01e-0320092M7251
CoexpressionGSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP

CADM1 AFF2

2.01e-0320092M5127
CoexpressionGSE23695_CD57_POS_VS_NEG_NK_CELL_DN

TNRC6C KDM6B

2.01e-0320092M7786
CoexpressionGSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP

ANK3 AFF2

2.01e-0320092M5122
CoexpressionGSE360_CTRL_VS_L_DONOVANI_DC_DN

AFF2 KDM6B

2.01e-0320092M5144
CoexpressionTABULA_MURIS_SENIS_PANCREAS_PANCREATIC_DELTA_CELL_AGEING

CADM1 KDM6B

2.01e-0320092MM3817
CoexpressionGSE8515_IL1_VS_IL6_4H_STIM_MAC_UP

PHC3 KDM6B

2.01e-0320092M5766
CoexpressionGSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP

TNRC6C HUWE1

2.01e-0320092M6035
CoexpressionGSE24210_RESTING_TREG_VS_TCONV_UP

TNRC6C PHC3

2.01e-0320092M7839
CoexpressionGAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP

ANK3 HUWE1

2.15e-0320792MM475
CoexpressionLAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE

ANK3 CADM1

2.17e-0320892M39233
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500

ANK3 TNRC6C HUWE1

6.73e-0520193gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlasDevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000

ANK3 CADM1 TNRC6C HUWE1

2.37e-0481994gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000

ANK3 TNRC6C HUWE1

4.24e-0437593gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_1000

HUWE1 KDM6B

4.36e-047592gudmap_developingGonad_e14.5_ ovary_1000_k4
CoexpressionAtlasDevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500

ANK3 HUWE1

4.72e-047892gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5
CoexpressionAtlasDevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000

TNRC6C HUWE1

4.84e-047992gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500

ANK3 TNRC6C HUWE1

5.20e-0440293gudmap_developingKidney_e15.5_anlage of loop of Henle_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500

ANK3 TNRC6C HUWE1

5.39e-0440793gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlasDevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500

CADM1 TNRC6C HUWE1

5.95e-0442193gudmap_developingKidney_e15.5_Peripheral blastema_500
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

5.11e-061799356db12467b445f2b8ef92af50779eeab10413eb2
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.02e-0618993ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.11e-06190937fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.11e-061909310b02c62e72bfea9767e3e751011436925da823e
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.11e-06190937e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.11e-06190931004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 KRT13 CADM1

6.41e-0619393a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.51e-06194936a4e7f1bf67bad94cd8c472e7c66798b0c25ba01
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.61e-06195934a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.61e-06195937a32a8535c29b819dacba901d0658280a2631c94
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2 NUP62CL

6.71e-06196936708026bafd19c35c5c4e81911344d36a0f508cd
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type.

ANK3 TNRC6C KDM6B

7.13e-0620093c92e4fc0442404481fcac623d691dae6215b852d
ToppCellfacs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 AFF2

1.03e-047792557f7518e9a89d99f3f2474720deb9cde10e1054
ToppCellfacs-Lung-EPCAM-24m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 AFF2

1.11e-0480926720438bf51831e98402a700dfc25bd57e0c6798
ToppCellASK452-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

KRT13 PHC3

1.26e-048592523a532e91aa271faab67d0256919b67af2bd7d8
ToppCellGlobus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

KRT13 NUP62CL

3.08e-0413392a653282bf871dc9eb47fbf1d55b1eb32ae749c04
ToppCellGlobus_pallidus-Macroglia-CSF_related-EPENDYMAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

KRT13 NUP62CL

3.08e-04133922d0cade52d79c3d0b6f77418103244150e2ea7fb
ToppCellGlobus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

KRT13 NUP62CL

3.08e-041339225ea1d82a0fc9fed191b9dd33f2a35404a665e7d
ToppCellGlobus_pallidus-Macroglia-CSF_related|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

KRT13 NUP62CL

3.08e-041339251c60b6d5648968783bffbb22c28d9abaf6243d5
ToppCellGlobus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

KRT13 NUP62CL

3.08e-04133922caaacb4fb4358c5589c81eaf8dffb85f318fb13
ToppCellEpithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4)

ANK3 CADM1

3.71e-04146924511916904c1fac252cb68e871b782207f8137b3
ToppCellfacs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 CADM1

4.02e-0415292d279592c501fca9cb474ad916fea32282e6969cb
ToppCellfacs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 CADM1

4.02e-04152923b59143b2b4ee24eb6378f87ff568124193256e9
ToppCellASK452-Epithelial-Type_2|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

KRT13 PHC3

4.23e-0415692e2b8d65c38cedb8ec6c3c1b138957145af931c51
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 CADM1

4.40e-04159928680b054622f573a82b1625fb93c2d5db81d1034
ToppCell10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ANK3 PHC3

4.45e-041609260fa1c717410aad7e8647703cb416cd7617cac29
ToppCelldroplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 CADM1

4.51e-0416192441ebd3c029861d833fbcf8a68fc740d9de8ef2f
ToppCellfacs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 KDM6B

4.51e-0416192248487415a0601d57ef2a6692e22a61368d0b9c8
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CADM1

4.56e-0416292d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CADM1

4.56e-041629206f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

ANK3 PHC3

4.56e-0416292b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells)

ANK3 CADM1

4.68e-0416492beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCell343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells)

ANK3 CADM1

4.68e-0416492d005cfd821b87548b075120bffe65a0be9860463
ToppCellPND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass

KRT13 CADM1

4.73e-0416592b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637
ToppCellLV-16._Neuronal|World / Chamber and Cluster_Paper

ANK3 CADM1

4.73e-04165926ed52cb756d21addf46c7f6c457458b01339fe04
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 NUP62CL

4.79e-0416692575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 CADM1

4.79e-0416692c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCellPND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUP62CL KDM6B

4.90e-0416892cc0dd43d5cda01e643d8e8d74ec7617d61890760
ToppCell10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue

CADM1 NUP62CL

4.90e-0416892e8bd090de5c9fe286b08a8b314ce12cf988184f0
ToppCellControl|World / group, cell type (main and fine annotations)

ANK3 CADM1

4.90e-0416892a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCellLA-16._Neuronal|LA / Chamber and Cluster_Paper

ANK3 CADM1

4.90e-0416892c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCellCOVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANK3 CADM1

4.90e-041689288c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCelldroplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 CADM1

4.96e-0416992149a4f83da15bdeb170e980fb5b5b1af89ae07a6
ToppCelldroplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

4.96e-04169924ac21e8199de4b6917eacadc56fffc6d886ee643
ToppCellLV-16._Neuronal|LV / Chamber and Cluster_Paper

ANK3 CADM1

4.96e-0416992a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 CADM1

5.02e-0417092a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCelldroplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KRT13 CADM1

5.02e-0417092bf589c4297ccc90e5f51e3d0fcc229548af4fcef
ToppCellControl-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations)

ANK3 CADM1

5.02e-0417092e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9

ANK3 KRT13

5.08e-0417192adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 KDM6B

5.14e-0417292bd73fd3520064d430a153cfdd5c2858b6c184c59
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 KDM6B

5.14e-041729247ee78ed3ba6516dad8f12dbf70bca5ed1c60aff
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CADM1 AFF2

5.14e-041729203a0aff6b7971093a4347b5ed12546d78374c56f
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CADM1

5.20e-041739245808cf69122c16b9d2b5ffa06d15392c55954b7
ToppCellE18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass

ANK3 CADM1

5.20e-0417392f6e36ea98a9c669ff393d141455aaecef083f738
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 CADM1

5.20e-04173920c74bdb40e635d906fd180412c23bf7fed61621e
ToppCellP07-Epithelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ANK3 CADM1

5.20e-04173928b10087a917b825809d35a2b2b349c73a2782472
ToppCellCOVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type

ANK3 CADM1

5.20e-04173926fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 CADM1

5.20e-0417392b799c06a6a5754668e789f70c0c8bc1508568575
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CADM1

5.20e-04173927fa9dbcb258c3ab974490063951620e2def03db1
ToppCellP03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ANK3 CADM1

5.26e-041749223c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07
ToppCellE17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ANK3 CADM1

5.26e-041749268914ec843f58ecff3e6412544a341daf8a01cac
ToppCellP07-Epithelial-alveolar_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ANK3 CADM1

5.26e-04174922739de68e0266054694f99807cfb1f07b6bbb371
ToppCelldroplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT13 CADM1

5.26e-04174922afa5eea54b67c549c5058ece98296eee3829c11
ToppCellfacs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF2 NUP62CL

5.32e-0417592a7310950e8d51b3004ea3aee8ce9948fe8655112
ToppCell10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK3 CADM1

5.32e-04175928b010220cdfb680ec839572f4933adfb85045ea6
ToppCellfacs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF2 NUP62CL

5.32e-0417592d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc
ToppCell10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK3 CADM1

5.32e-04175920b579aeadcc06be83627391c0b01bd8605fdbdf3
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ANK3 CADM1

5.32e-0417592bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK3 CADM1

5.32e-0417592bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1
ToppCell(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class

ANK3 CADM1

5.38e-0417692ce2c32b5ce0da848eb4da35ce4d215cdf74d9113
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CADM1 AFF2

5.38e-0417692e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CADM1 AFF2

5.38e-0417692f931192e3cc65414e2245354f443473696cc7ce8
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

HUWE1 NUP62CL

5.44e-041779282fdd6185b368f54f03de389427cbe3071d21a99
ToppCellfacs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AFF2 NUP62CL

5.50e-0417892bc0336692b84bd0fa49747ed5a031b8ed8afa0fd
ToppCellfacs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AFF2 NUP62CL

5.50e-04178928bae5db100f4563aa1fc7f881e7f8c59d669e37a
ToppCelldroplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

5.50e-04178923e8aacb27ed1a3c3978e21dddddd0828f8000692
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 CADM1

5.50e-0417892f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCelldroplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF2 NUP62CL

5.56e-0417992bfc226bcf0b93525992344f968268a261d86fcbf
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 CADM1

5.56e-0417992cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CADM1 AFF2

5.56e-04179927c8a2fa1326c73dc9e774df645b572864fd97133
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ANK3 CADM1

5.56e-0417992815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCelldroplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF2 NUP62CL

5.56e-041799236ad18f52e175ab636ceaa3be81212fa362c96c1
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CADM1

5.56e-0417992bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 CADM1

5.56e-0417992d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

KRT13 CADM1

5.56e-0417992d5763912a4ce7188535675e338799b856edb9dda
ToppCelldroplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

5.63e-0418092da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell5'-Adult-SmallIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK3 CADM1

5.63e-0418092ebd6e719a03f25155fa8181be19469d04d6d10a6
ToppCellRA-16._Neuronal|RA / Chamber and Cluster_Paper

ANK3 CADM1

5.63e-04180925842febfdabac61ce970254fb0ef17a628f1b8c0
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

5.63e-0418092dad458398683ff80a6e207bdc08e257d1bb757d6
ToppCell5'-Adult-SmallIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK3 CADM1

5.63e-04180925e6e38ee0758ef2342a6a821c78ed24b57bb7b11
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CADM1 AFF2

5.63e-04180928bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2
ToppCelldroplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

5.63e-04180925b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

ANK3 CADM1

5.63e-0418092198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCelldroplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

5.63e-041809250758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CADM1

5.63e-0418092d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7
ToppCell5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK3 CADM1

5.63e-0418092b88cd7ae922782176c057342d1b9eb9b8e5e7204
ToppCellfacs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AFF2 NUP62CL

5.69e-0418192dff264815a3569f5666d0bbc3867c0496cd78774
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

ANK3 HUWE1

5.69e-0418192f2315414e714ac86211546a935660c4be6e85f1b
ToppCellP03-Epithelial|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ANK3 CADM1

5.69e-0418192de0466072f5b2ab8db3d9bab31e3205d1ff7cfb7
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ANK3 CADM1

5.69e-0418192576da14ab3107f89e1f44a4a439d1bef5bb42370
Drugtorcetrapib

ANK3 PHC3 AFF2 NUP62CL

5.94e-0634294ctd:C483909
Drugclotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA

ANK3 KRT13 NUP62CL

4.28e-0518593905_UP
Drug5182598; Down 200; 25uM; MCF7; HT_HG-U133A_EA

KRT13 CADM1 NUP62CL

4.42e-0518793868_DN
DrugIndomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A

ANK3 CADM1 NUP62CL

4.93e-05194935049_DN
DrugHydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A

ANK3 CADM1 PHC3

5.00e-05195932311_DN
DrugErgocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A

ANK3 CADM1 PHC3

5.08e-05196933817_UP
DrugConvolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CADM1 NUP62CL KDM6B

5.16e-05197937230_DN
DrugHydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A

KRT13 CADM1 KDM6B

5.16e-05197937019_DN
DrugSerotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A

CADM1 NUP62CL KDM6B

5.24e-05198933311_DN
DrugSaquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A

HUWE1 PHC3 AFF2

5.24e-05198936127_UP
DrugLycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A

HUWE1 PHC3 AFF2

5.24e-05198933891_UP
DrugRacecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

CADM1 PHC3 NUP62CL

5.24e-05198936231_UP
DrugLidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A

ANK3 CADM1 KDM6B

5.31e-05199935804_DN
DrugS(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; PC3; HT_HG-U133A

ANK3 PHC3 AFF2

5.31e-05199934634_DN
Drugarachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A

ANK3 KRT13 CADM1

5.39e-0520093604_UP
Drugampicillinoic acid

HUWE1 AFF2

1.19e-044292CID006453491
Drugbromodeoxyuridine

KRT13 PHC3 AFF2

3.49e-0437693CID000006035
DrugMPC-1304

KRT13 CADM1

5.11e-048792CID000002225
DrugThiophosphonoacetic Acid

ANK3 HUWE1

6.21e-049692CID005459392
DrugAC1L9LT0

ANK3 CADM1

1.02e-0312392CID000448294
DrugAC1O4QI2

CADM1 PHC3

1.26e-0313792CID006398444
Drugrottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA

AFF2 KDM6B

1.93e-0317092941_UP
DrugCiclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A

ANK3 KDM6B

2.02e-03174922456_UP
Drugpioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A

ANK3 KDM6B

2.23e-03183927088_DN
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HUWE1 PHC3

2.23e-03183926166_UP
DrugHexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A

HUWE1 AFF2

2.28e-03185922457_UP
Drugpioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A

CADM1 KDM6B

2.30e-03186925930_UP
DrugDicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A

ANK3 PHC3

2.33e-03187924323_DN
Drug2f34

TNRC6C HUWE1

2.35e-0318892CID006420160
DrugDicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A

ANK3 HUWE1

2.35e-03188924405_UP
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

KRT13 NUP62CL

2.35e-03188921667_UP
DrugAmitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A

PHC3 KDM6B

2.35e-03188921865_DN
DrugNocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A

PHC3 NUP62CL

2.37e-03189926793_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A

PHC3 KDM6B

2.37e-03189925084_DN
DrugPerphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A

HUWE1 KDM6B

2.40e-03190924637_UP
Drugcolcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA

CADM1 KDM6B

2.40e-03190921103_UP
DrugGabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A

PHC3 NUP62CL

2.40e-03190923253_DN
DrugHarpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A

ANK3 PHC3

2.42e-03191924981_DN
DrugIsotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A

CADM1 NUP62CL

2.42e-03191927438_DN
DrugDNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A

PHC3 KDM6B

2.45e-03192927548_UP
Drug17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A

NUP62CL KDM6B

2.45e-03192921638_DN
Drugpioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A

ANK3 PHC3

2.45e-03192925930_DN
Drug5707885; Down 200; 50uM; PC3; HT_HG-U133A

CADM1 PHC3

2.45e-03192926438_DN
DrugSulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A

ANK3 KDM6B

2.47e-03193923667_DN
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A

HUWE1 NUP62CL

2.47e-03193924322_UP
DrugEthopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; PC3; HT_HG-U133A

ANK3 AFF2

2.47e-03193926697_DN
DrugDanazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

PHC3 NUP62CL

2.47e-03193925315_UP
Drugikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA

CADM1 KDM6B

2.47e-0319392866_DN
DrugIohexol [66108-95-0]; Down 200; 4.8uM; MCF7; HT_HG-U133A

ANK3 PHC3

2.47e-03193923322_DN
DrugSimvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A

HUWE1 PHC3

2.50e-03194924828_UP
DrugNS-398; Up 200; 10uM; MCF7; HT_HG-U133A

ANK3 NUP62CL

2.50e-03194926897_UP
DrugTiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A

PHC3 AFF2

2.50e-03194924171_DN
DrugCyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A

CADM1 PHC3

2.50e-03194924470_DN
Druglomustine; Down 200; 100uM; MCF7; HT_HG-U133A

ANK3 KRT13

2.50e-03194927089_DN
DrugFusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A

ANK3 PHC3

2.50e-03194924105_DN
DrugChlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HT_HG-U133A

PHC3 NUP62CL

2.50e-03194926761_DN
DrugMorantel tartrate [26155-31-7]; Down 200; 10.8uM; HL60; HT_HG-U133A

PHC3 KDM6B

2.50e-03194921840_DN
DrugNocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A

ANK3 NUP62CL

2.50e-03194922076_UP
DrugFlurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A

PHC3 KDM6B

2.50e-03194926039_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; HL60; HT_HG-U133A

ANK3 AFF2

2.50e-03194922546_UP
Drugpioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A

ANK3 KDM6B

2.50e-03194926893_DN
DrugDomperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A

HUWE1 AFF2

2.50e-03194925701_UP
DrugGSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A

PHC3 NUP62CL

2.53e-03195927106_UP
DrugSulindac [38194-50-2]; Up 200; 11.2uM; HL60; HT_HG-U133A

CADM1 AFF2

2.53e-03195921857_UP
DrugSB 202190; Down 200; 1uM; PC3; HT_HG-U133A

ANK3 NUP62CL

2.53e-03195927058_DN
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A

CADM1 PHC3

2.53e-03195922308_DN
DrugMegestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A

ANK3 HUWE1

2.53e-03195923091_UP
DrugPrednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

HUWE1 KDM6B

2.53e-03195924577_UP
DrugThonzonium bromide [553-08-2]; Down 200; 6.8uM; MCF7; HT_HG-U133A

CADM1 NUP62CL

2.53e-03195926457_DN
DrugMycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A

PHC3 AFF2

2.53e-03195924019_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A

PHC3 KDM6B

2.53e-03195921836_DN
DrugThiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A

NUP62CL KDM6B

2.53e-03195925520_DN
DrugMecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A

PHC3 KDM6B

2.53e-03195923525_DN
DrugPNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A

CADM1 KDM6B

2.53e-03195923732_DN
DrugMeptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A

ANK3 AFF2

2.53e-03195922906_UP
DrugCephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A

ANK3 AFF2

2.53e-03195922517_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A

ANK3 KDM6B

2.53e-0319592421_UP
DrugThiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A

ANK3 KDM6B

2.53e-03195927033_UP
Drugprostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A

ANK3 PHC3

2.53e-03195926552_DN
DrugGlipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A

ANK3 HUWE1

2.53e-03195924991_UP
DrugCanrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A

AFF2 NUP62CL

2.53e-03195927135_UP
Drugtrifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A

NUP62CL KDM6B

2.53e-03195921649_DN
Drug15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A

ANK3 NUP62CL

2.53e-03195925591_DN
DrugClindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A

PHC3 KDM6B

2.53e-03195927172_DN
Drug(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A

CADM1 HUWE1

2.53e-03195923789_UP
Diseasemetabolite measurement

ANK3 CADM1

1.18e-0256092EFO_0004725
Diseasebipolar disorder

ANK3 HUWE1

1.25e-0257792MONDO_0004985
Diseasemonocyte percentage of leukocytes

AFF2 KDM6B

1.97e-0273192EFO_0007989

Protein segments in the cluster

PeptideGeneStartEntry
TATATTTTTTTTIST

AFF2

1011

P51816
TTTTTTTISTITSTI

AFF2

1016

P51816
VTTTTTTTTTTTATQ

KDM6B

751

O15054
TSVTTTSSASVTTTS

KRT13

431

P13646
SSTTTATSTTSTTTT

HUWE1

3481

Q7Z6Z7
SVSTTTSSTTTTTIT

PHC3

11

Q8NDX5
TSSTTTTTITTSSSR

PHC3

16

Q8NDX5
TTTTTTTTTTTTTIL

CADM1

341

Q9BY67
STCVTTTTTTATTTT

ANK3

3956

Q12955
TTTTTATTTTTTTTT

ANK3

3961

Q12955
ATTTTTTTTTTTTSC

ANK3

3966

Q12955
TTTNTTTTTTTTTSN

TNRC6C

756

Q9HCJ0
TTSTTTTATFTTNTT

NUP62CL

21

Q9H1M0